Bioequivalence Study of Two Formulatiosns With the Asscociaton of Efavirenz, Emtricitabine and Tenofovir

NCT03309566 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Efavirenz, tenofovir disoproxil fumarate and emtricitabine

Sponsor

Laboratorio Elea Phoenix S.A.